ANTICANCER EXPORTER IN INDIA
Actiza Pharma offers the most incredible and effective as well as the widest ranges of anticancer products with the entire various pharma medicines, tablets, capsules and injectables, and more. We ensure you our whole pharma product ranges which are all manufactured with the help of utilizing top-quality genuine chemical agents that ensure 100% guaranteed results. We are also a reliable anti-cancer exporter and manufacturer in India that offers GMP, WHO certified items. Our all anti-cancer drugs are also certified and granted in the R&D labs, effective production facility, increased manufacturing processes, and more.
However, cancer causes around 20% of deaths in India as per current research. In addition, it is considered as a huge price to prevail over. Most company Pharma manufacturers precede in this part for making various medicines. Actiza Pharma is one of the best-known anti-cancer exporters in India that can carry out their major endeavor that protecting the lives of individuals.
With the advanced time of therapy of this cancer disease which is incurable Research and development established a treatment that is implemented with the top and innovative medical technique. Therefore, contact us at an Anti-cancer medicine exporter in India. In addition we are dedicated to distributing all chemical manufacturing processes with the greatest care and satisfaction.
Our facilities Accredited & Complied
With WHO-GMP standards, We offer seamless service from the Plant registration to Development/Registration, and Commercialisation of the products globally
40+
Exporting Countries
12+
Years Of Experience
500+
Clients Globally
2000+
Product Lines
550+
Ready Dossiers
Have a query, send us a quick enquiry
* We will contact you shortly over an Email or Phone.
The Growing Global Burden of Cancer
Cancer is steadily rising as a pressing global challenge. In 2022, there were 20 million new cancer cases and 9.7 million fatalities. This shows we need to pay urgent attention to this health crisis. Lung cancer is the most common type of cancer, followed closely by breast cancer. People in poorer countries often go without proper cancer care, making survival a struggle. The World Health Organization urges immediate action to reduce healthcare differences.
India’s Role in Global Anticancer Drug Supply
India has emerged as a key contender in the global anticancer drug arena. We create and export quality medicines at prices everyone can afford. This promotes global access to healthcare.
Indian firms invest in research and development for new treatments.
India exports $2.2 billion of anticancer drugs, ranking third globally in pharmaceutical production.
Indian medicines cost 80% less than those in developed nations.
Over world wide countries receive anticancer medicines from India. The US is the biggest market, making up 30% of all exports.
Overview of Anticancer Drugs Manufactured & Exported from India
India creates many important anticancer drugs. These medications are crucial in the fight against cancer. India exports essential treatments that help people around the globe combat diseases.
Chemotherapy Drugs
Chemotherapy is intended to eliminate or halt the development of cancer cells. Doctors use a range of drugs to do this, including cyclophosphamide and methotrexate.
Targeted Therapy Drugs
Targeted therapy drugs zero in on specific cancer cells. This helps protect healthy cells from damage—medications like imatinib and palbociclib target cancer cells.
Immunotherapy Drugs
Immunotherapy boosts the body’s natural defence against cancer. It uses two key tools: immune checkpoint inhibitors and monoclonal antibodies.
Hormonal Therapy Drugs
Hormonal therapy is a treatment for cancers that need hormones to grow, like breast cancer. Drugs like Letrozole and tamoxifen stop the body from making these hormones.
Biosimilars & Monoclonal Antibodies
Biosimilars are budget-friendly versions of approved biologic drugs. Rituximab and similar antibodies attack cancer cells. This boosts the chances of successful treatment.
India’s Anticancer Drug Export Market: Data & Statistics
India has risen as a leader in exporting affordable anticancer medicines. In 2023, our oncology drug exports reached an impressive $3.2 billion. Our commitment to accessible treatments improves the lives of cancer patients globally.
Leading Anticancer Drug Exporters in India
India has several major pharmaceutical companies that sell low-cost, effective cancer treatments worldwide. These companies supply cancer treatments worldwide.
As a WHO-GMP-certified exporter, we offer premium cancer medicines. We build our products on a quality promise: safe and effective every time.
The company exports oncology APIs and generic cancer medicines. It helps countries access better cancer treatments at a lower cost.
They are pioneering the development of biosimilars. This makes cancer treatments more affordable and accessible for patients around the world.
A prominent supplier of chemotherapy drugs. They ensure cancer patients can afford life-saving medicines and access the necessary care.
They focus on monoclonal antibodies and biosimilars. They aim to create innovative cancer drugs that benefit patients globally.
Anti-Cancer Medicines Need to Play Vital Roles, like
Treating cancer often involves using medicines that specifically target and kill cancer cells. This helps tackle a range of different cancers. Here are some important roles they play:
General Side Effects of Anticancer Medicines
Anticancer medicines have side effects which affect people differently. The treatment type and individual characteristics decide who experiences them. Several side effects include:
Regulatory Framework & WHO-GMP Certification
There are regulations for cancer medicines. Their top concern is safety, effectiveness, and keeping high standards. To ensure quality, they stick to strict manufacturing and testing standards.
WHO-GMP certification ensures that:
This accreditation establishes public trust. It ensures that patients get the high-quality care and effective treatment they need to get better.
Challenges in Anticancer Drug Export from India
India’s anticancer drug exports are on the rise, but there are still hurdles to overcome. These problems must be addressed in order to maintain success.
Each country has a unique regulatory environment. Exporters face a tough task in keeping up with changing rules.
Indian companies must improve their manufacturing processes. This will help them meet global standards and pass safety checks.
Balancing low prices with high costs is tough due to competition from China and Bangladesh.
Companies face fierce competition from global suppliers. Logistical issues can delay meeting export demands.
Future Trends & Growth Opportunities
India’s future in exporting anticancer drugs looks bright. The demand for affordable treatments is growing worldwide. India’s skill in producing quality generic drugs presents a strong chance for growth. Companies in India should ensure they follow the rules, keep quality high, and price things right. To remain competitive, they must spend in research and development.
Why Choose Actiza for Anticancer Medicines?
ACTIZA stands out as a reliable choice for anticancer medicines. Here’s why:
we sends life-saving anticancer drugs to more than 50 countries. This ensures that patients worldwide can access these vital treatments.
We craft every product to meet WHO-GMP standards so you can rely on its quality, purity, and safety.
The company supplies a range of drugs, such as chemotherapy, immunotherapy, and targeted therapy, to address diverse patient needs.
Conclusion
To sum it up, India is a crucial player in making affordable, top-notch cancer medicines available globally, which helps ease the increasing global pressure of cancer. We prioritizes research, innovation, and high-quality standards. The company is a reliable source of life-saving cancer treatments globally.